Showing results (131-140 of 220) with videos related to
Sort By:
Pageof 22
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 20, 2008
A comparison of benzodiazepine and related drug use in Nova Scotia and AustraliaAlesha J Smith, Ingrid Sketris, Charmaine Cooke, et al.Stress and Health : Journal of the International Society for the Investigation of Stress|April 7, 2025
Pandemic Concerns, Occupational Stressors, Burnout, and Psychological Distress Among U.S. Air Force Remotely Piloted Aircraft Personnel: A Multidimensional Mediation ModelRobert P Tett, Nicole Devlin, Kristin Galloway, et al.Pharmacoepidemiology and Drug Safety|September 2, 2014
Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policyGeeske Peeters, Susan E Tett, Emma L Duncan, et al.Pharmacoepidemiology and Drug Safety|January 9, 2008
A comparison of antidepressant use in Nova Scotia, Canada and AustraliaAlesha J Smith, Ingrid Sketris, Charmaine Cooke, et al.Drugs & Aging|February 1, 2017
New-Onset Diabetes After Statin Exposure in Elderly Women: The Australian Longitudinal Study on Women's HealthMark Jones, Susan Tett, Geeske M E E Peeters, et al.British Journal of Clinical Pharmacology|June 26, 2001
Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindololA S Gross, A J McLachlan, I Minns, et al.Therapeutic Drug Monitoring|February 21, 2018
Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant RecipientsEmily K Brooks, Susan E Tett, Nicole M Isbel, et al.Arthritis Care & Research|June 27, 2014
Is statin use associated with new joint-related symptoms, physical function, and quality of life? Results from two population-based cohorts of womenGeeske Peeters, Susan E Tett, Philip G Conaghan, et al.Therapeutic Drug Monitoring|February 24, 2001
Analytical validation for a series of marker compounds used to assess renal drug elimination processesA J McLachlan, A S Gross, J L Beal, et al.Cardiovascular Therapeutics|November 19, 2016
Ezetimibe: Use, costs, and adverse events in AustraliaSamantha A Hollingworth, Remo Ostino, Michael C David, et al.Pageof 22